Diabetes News and Research

Latest Diabetes News and Research

Osteocalcin hormone can regulate glucose levels: Research

Researchers led by Columbia University Medical Center have discovered that the skeleton plays an important role in regulating blood sugar and have further illuminated how bone controls this process. The finding, published in Cell, is important because it may lead to more targeted drugs for type 2 diabetes.

23 Jul 2010

Bristol-Myers Squibb second-quarter net sales increase 2% to $4.8 billion

Bristol-Myers Squibb Company today reported results for the second quarter of 2010 which featured data on key marketed and investigational compounds in its oncology, diabetes and cardiovascular franchises, and growth in sales and EPS. The company also confirmed guidance for 2010 and minimum guidance for non-GAAP EPS in 2013.

22 Jul 2010

Four areas that impact weight, obesity in women identified

The information gap and general lack of understanding of obesity's unique and disproportionate impact on women contributes to the challenges of the 65 million American women who are considered overweight or obese, said the Strategies to Overcome and Prevent (STOP) Obesity Alliance Task Force on Women at a meeting on Capitol Hill today.

22 Jul 2010

Medco second-quarter GAAP diluted EPS increases 20.3% to $0.77

Medco Health Solutions, Inc. today reported second-quarter 2010 GAAP diluted EPS of $0.77, up 20.3 percent compared to $0.64 for the second quarter of 2009. Adjusting for the amortization of intangible assets that existed when Medco became a publicly traded company in 2003, second-quarter 2010 diluted earnings per share increased 20.3 percent to $0.83, from $0.69 in the second quarter of 2009.

22 Jul 2010

New understanding on insulin resistance, action of diabetes drugs may lead to safer medication

A new understanding of insulin resistance and the action of diabetes drugs such as Avandia and Actos could pave the way for improved medications that are more selective and safer, say scientists from Dana-Farber Cancer Institute and The Scripps Research Institute.Our findings strongly suggest that good and bad effects of these drugs can be separated by designing second-generation drugs that focus on the newly uncovered mechanism, said Bruce Spiegelman, PhD, of Dana-Farber, senior author on a report appearing in the July 22 issue of Nature.

22 Jul 2010

Fatal risk of software defects in implantable medical devices

Software vulnerabilities in life-sustaining medical devices such as pacemakers and infusion pumps pose a growing threat to public health, warns a new report published by the Software Freedom Law Center (SFLC).

22 Jul 2010

Genomics researchers study role of protein in metabolic disorders, heart disease

Studying a protein already known to play an important role in type 2 diabetes and cancer, genomics researchers have discovered that it may have an even broader role in disease, particularly in other metabolic disorders and heart disease. In finding unsuspected links to other disease-related genes, the scientists may have identified future targets for drug treatments.

22 Jul 2010

Scientists uncover new mechanism that reduces risk of type 2 diabetes, cardiovascular disease

In a joint study, scientists from The Scripps Research Institute and the Dana-Farber Cancer Institute at Harvard University have uncovered a novel mechanism that dramatically increases insulin sensitivity and reduces the risk of developing type 2 diabetes and cardiovascular disease.

22 Jul 2010

Study: 17% of homeless people in Toronto report unmet health care needs

Most studies of healthcare for homeless people have been conducted in the United States, where it's not surprising that lack of money and insurance are the main barriers.

22 Jul 2010

Report on Malaysian SMBG devices and strips market

According to the International Diabetes Federation, there were a staggering 185.5 million diabetics globally in 2009, with Asia Pacific accounting for 76.5 million of them. Out of this, Malaysia contributed 1.33 million diabetics, of which only 0.6 million were diagnosed.

22 Jul 2010

WHO, IOC team up to promote healthy lifestyle choices for noncommunicable disease prevention

WHO and the International Olympic Committee are teaming up to promote healthy lifestyle choices, including physical activity, sports for all, Tobacco Free Olympic Games, and the prevention of childhood obesity. As outlined in a memorandum of understanding signed today in Lausanne, the WHO and IOC will work at both the international and country level to promote activities and policy choices to help people reduce their risk of noncommunicable diseases such as cardiovascular disease, cancers, and diabetes.

22 Jul 2010

TCF7L2 protein may play important role in heart disease, other metabolic disorders: Researchers

22 Jul 2010

Amylin reports $164.4M total revenue for quarter ended June 30, 2010

Amylin Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2010. The Company reported total revenue of $164.4 million for the quarter ended June 30, 2010, which includes net product sales of $162.5 million. Net loss, excluding a restructuring charge of $3.4 million, was $40.8 million, or $0.28 per share.

22 Jul 2010

Capsaicin may cause weight loss, fight fat buildup: Study

Capsaicin, the stuff that gives chili peppers their kick, may cause weight loss and fight fat buildup by triggering certain beneficial protein changes in the body, according to a new study on the topic. The report, which could lead to new treatments for obesity, appears in ACS' monthly Journal of Proteome Research.

22 Jul 2010

Researchers speculate about risks, rewards of making clinicians' notes transparent to patients

Technology has placed vast amounts of medical information literally a mouse click away. Yet what often may be central - a doctor's notes about a patient visit - has traditionally not been part of the discussion. In effect, such records have long been out of bounds.

22 Jul 2010

SWHR hosts briefing on urinary incontinence, overactive bladder

The Society for Women's Health Research (SWHR) hosted the Capitol Hill briefing, The Bladder Matters: What Women Need to Know on Thursday, July 15, which highlighted startling statistics and an insightful patient perspective. Featuring noted researchers, physicians, Hill staff, and a UI-afflicted patient, the aim of this widely attended briefing was to detail current research on urinary incontinence (UI) and present future outlooks.

22 Jul 2010

Study identifies treatment strategies that can slow progression of eye disease associated with diabetes

The VA Maryland Health Care System participated in a landmark national study of more than 10,251 high-risk diabetic adults across the nation, testing if three complementary treatment strategies can reduce the high rate of heart disease and stroke associated with type 2 diabetes and if these treatment strategies can also slow the progression of eye disease associated with diabetes, the leading cause of blindness in working-age Americans.

22 Jul 2010

Survey links autism with digestive problems, intestinal inflammation

Autism is the fastest growing developmental disorder in the world. With 1 child in 91 facing the disorder, the diagnosis is more common than pediatric cancer, diabetes, and AIDS combined.

22 Jul 2010

DenteMax offers largest network approved for Medicare dental benefits

DenteMax, the nation's largest seamless dental PPO network, now also offers the largest seamless network approved for Medicare dental benefits. The new network provides access to more than 65,000 approved dentist access points and is built on the strong foundation of the commercial DenteMax network.

22 Jul 2010

Ampio Pharmaceuticals commences Optina Phase II clinical trial for diabetic macular edema

Ampio Pharmaceuticals, Inc. today announced the initiation of a Phase II clinical trial of Optina™ for the treatment of diabetic macular edema, an early stage of diabetic retinopathy. Diabetic macular edema is responsible for most vision loss in patients with diabetes mellitus.

22 Jul 2010

Diabetes News and Research

Latest Diabetes News and Research

Osteocalcin hormone can regulate glucose levels: Research

Bristol-Myers Squibb second-quarter net sales increase 2% to $4.8 billion

Four areas that impact weight, obesity in women identified

Medco second-quarter GAAP diluted EPS increases 20.3% to $0.77

New understanding on insulin resistance, action of diabetes drugs may lead to safer medication

Fatal risk of software defects in implantable medical devices

Genomics researchers study role of protein in metabolic disorders, heart disease

Scientists uncover new mechanism that reduces risk of type 2 diabetes, cardiovascular disease

Study: 17% of homeless people in Toronto report unmet health care needs

Report on Malaysian SMBG devices and strips market

WHO, IOC team up to promote healthy lifestyle choices for noncommunicable disease prevention

TCF7L2 protein may play important role in heart disease, other metabolic disorders: Researchers

Amylin reports $164.4M total revenue for quarter ended June 30, 2010

Capsaicin may cause weight loss, fight fat buildup: Study

Researchers speculate about risks, rewards of making clinicians' notes transparent to patients

SWHR hosts briefing on urinary incontinence, overactive bladder

Study identifies treatment strategies that can slow progression of eye disease associated with diabetes

Survey links autism with digestive problems, intestinal inflammation

DenteMax offers largest network approved for Medicare dental benefits

Ampio Pharmaceuticals commences Optina Phase II clinical trial for diabetic macular edema

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Diabetes News and Research

Latest Diabetes News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in